Ueda I, Matsuki H, Kamaya H, Krishna P R
Department of Anesthesia, Department of Veterans Affairs Medical Center, and University of Utah School of Medicine, Salt Lake City, Utah 84148, USA.
Biophys J. 1999 Jan;76(1 Pt 1):483-8. doi: 10.1016/S0006-3495(99)77216-4.
Ueda and Suzuki (1998. Biochim. Biophys. Acta. 1380:313-319; 1998. Biophys. J. 75:1052-1057) reported that myristic acid inhibited firefly luciferase in microM range in competition with luciferin, whereas anesthetics inhibited it in millimeter ranges noncompetitively with luciferin. Myristate increased, whereas anesthetics decreased, the thermal denaturation temperature. The present study showed that high pressure increased the steady-state light intensity of the halothane-doped firefly luciferase but decreased that of the myristate-doped firefly luciferase. The steady-state light intensity showed a maximum at 19.1 degrees C. At 19.1 degrees C, high pressure did not affect the light intensity in the absence of the inhibitors. In the presence of 0.5 mM halothane, however, 25 MPa pressure (maximum effect) increased the light intensity to 106.0% of the control without the inhibitor. In the presence of 2.5 microM myristate, 40 MPa pressure decreased the light intensity to 90.9% of the control. When the temperature was 25 degrees C in the absence of inhibitors, 40 MPa pressure increased the light intensity 119.2% of the ambient value. At 0.5 mM halothane, 40 MPa pressure further increased the light intensity to 106.1% above the control 40 MPa value. At 2.5 microM myristate, 40 MPa pressure decreased the light intensity to 90.1% of the control 40 MPa value. From the pressure dependence of the light intensity, the volume change DeltaV of the enzyme was estimated at 25 degrees C: 0.5 mM halothane increased DeltaV = +3.93 cm3 mol-1, whereas 2.5 microM myristate decreased DeltaV = -7.66 cm3 mol-1. Present results show that there are distinct differences between the specific and nonspecific ligands in their response to high pressure. Myristate, which competes with luciferin, decreased the protein volume and stabilized the conformation against thermal perturbation. Halothane, which does not compete with the substrate, increased the protein volume and destabilized the conformation.
上田和铃木(1998年,《生物化学与生物物理学报》1380:313 - 319;1998年,《生物物理杂志》75:1052 - 1057)报道,肉豆蔻酸在微摩尔范围内与荧光素竞争,抑制萤火虫荧光素酶,而麻醉剂在毫摩尔范围内与荧光素非竞争性抑制该酶。肉豆蔻酸盐提高热变性温度,而麻醉剂降低热变性温度。本研究表明,高压增加了氟烷掺杂的萤火虫荧光素酶的稳态光强度,但降低了肉豆蔻酸盐掺杂的萤火虫荧光素酶的稳态光强度。稳态光强度在19.1℃时达到最大值。在19.1℃时,在没有抑制剂的情况下,高压不影响光强度。然而,在存在0.5 mM氟烷的情况下,25 MPa压力(最大效应)使光强度增加到无抑制剂对照的106.0%。在存在2.5 μM肉豆蔻酸盐的情况下,40 MPa压力使光强度降低到对照的90.9%。在没有抑制剂时温度为25℃时,40 MPa压力使光强度增加到环境值的119.2%。在0.5 mM氟烷存在下,40 MPa压力进一步使光强度增加到比对照40 MPa值高106.1%。在2.5 μM肉豆蔻酸盐存在下,40 MPa压力使光强度降低到对照40 MPa值的90.1%。根据光强度的压力依赖性,在25℃时估计酶的体积变化ΔV:0.5 mM氟烷使ΔV = +3.93 cm³ mol⁻¹增加,而2.5 μM肉豆蔻酸盐使ΔV = -7.66 cm³ mol⁻¹降低。目前的结果表明,特异性和非特异性配体在对高压的反应上存在明显差异。与荧光素竞争的肉豆蔻酸盐降低了蛋白质体积,并使构象对热扰动稳定。不与底物竞争的氟烷增加了蛋白质体积,并使构象不稳定。